BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9655261)

  • 1. Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage.
    Hedlund TE; Duke RC; Schleicher MS; Miller GJ
    Prostate; 1998 Jul; 36(2):92-101. PubMed ID: 9655261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential involvement of the Fas receptor/ligand system in p53-dependent apoptosis in human prostate cancer cells.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    Prostate; 2000 Dec; 45(4):341-9. PubMed ID: 11102960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
    Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity.
    Frost P; Ng CP; Belldegrun A; Bonavida B
    Cell Immunol; 1997 Aug; 180(1):70-83. PubMed ID: 9316641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis.
    Frost PJ; Belldegrun A; Bonavida B
    Prostate; 1999 Sep; 41(1):20-30. PubMed ID: 10440872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis.
    Hyer ML; Voelkel-Johnson C; Rubinchik S; Dong J; Norris JS
    Mol Ther; 2000 Oct; 2(4):348-58. PubMed ID: 11020350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
    J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes.
    Ferrarini M; Imro MA; Sciorati C; Heltai S; Protti MP; Pellicciari C; Rovere P; Manfredi AA; Rugarli C
    Int J Cancer; 1999 May; 81(4):573-9. PubMed ID: 10225447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis induced in human colorectal carcinoma by anti-Fas antibody.
    Meterissian SH; Kontogiannea M; Po J; Jensen G; Ferdinand B
    Ann Surg Oncol; 1997 Mar; 4(2):169-75. PubMed ID: 9084855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
    Yao H; Song E; Chen J; Hamar P
    Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
    Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
    Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells.
    Hedlund TE; Meech SJ; Srikanth S; Kraft AS; Miller GJ; Schaack JB; Duke RC
    Cell Death Differ; 1999 Feb; 6(2):175-82. PubMed ID: 10200564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel.
    Symes JC; Kurin M; Fleshner NE; Medin JA
    Mol Cancer Ther; 2008 Sep; 7(9):3018-28. PubMed ID: 18790782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 modulates Fas-mediated apoptosis in human renal cell carcinoma cell lines.
    Hara I; Hara S; Miyake H; Arakawa S; Kamidono S
    Int J Oncol; 2001 Jun; 18(6):1181-5. PubMed ID: 11351249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas-mediated apoptosis in human prostatic carcinoma cell lines.
    Rokhlin OW; Bishop GA; Hostager BS; Waldschmidt TJ; Sidorenko SP; Pavloff N; Kiefer MC; Umansky SR; Glover RA; Cohen MB
    Cancer Res; 1997 May; 57(9):1758-68. PubMed ID: 9135020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.
    Shinohara H; Yagita H; Ikawa Y; Oyaizu N
    Cancer Res; 2000 Mar; 60(6):1766-72. PubMed ID: 10749152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Fas and granule exocytosis pathways in tumor-infiltrating T lymphocyte-induced apoptosis of autologous human lung-carcinoma cells.
    Dorothee G; Ameyar M; Bettaieb A; Vergnon I; Echchakir H; Bouziane M; Chouaib S; Mami-Chouaib F
    Int J Cancer; 2001 Mar; 91(6):772-7. PubMed ID: 11275978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.
    Aschkenazi S; Straszewski S; Verwer KM; Foellmer H; Rutherford T; Mor G
    Biol Reprod; 2002 Jun; 66(6):1853-61. PubMed ID: 12021072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.